Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate

Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure funding to support the effort and will now pursue “strategic alternatives” instead.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

Report a problem with this story

More in Health & Medicine

More from Wednesday 7 October →